Neurotechnologijos - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 598,958 | 625,624 | 584,841 | 687,166 | 119,065 | -33,968 | 58,698 | 68,309 |
| Profit before tax | - | 417,322 | 258,861 | 264,734 | -127,178 | -165,842 | - | - |
| Net profit | 377,757 | 354,443 | 219,995 | 224,771 | -127,178 | -165,842 | -104,073 | -27,616 |
| Equity | 410,757 | 387,443 | 482,438 | 612,209 | 380,325 | 214,483 | 110,410 | 82,794 |
| Liabilities | 73,081 | 26,444 | 55,261 | 47,691 | 39,664 | 66,497 | 101,060 | 50,631 |
| Non-current assets | 71,588 | 126,871 | 103,005 | 132,992 | 81,146 | 72,691 | 52,143 | 20,001 |
| Current assets | 411,775 | 278,704 | 425,513 | 501,123 | 309,965 | 205,430 | 158,577 | 111,749 |
| Total assets | 483,363 | 405,575 | 528,518 | 634,115 | 391,111 | 278,121 | 210,720 | 131,750 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 7,909 | - | 5,634 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +114.9% | +4.5% | -6.5% | +17.5% | -82.7% | - | - | +16.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 78.2% | 87.4% | 41.6% | 35.4% | -32.5% | -59.6% | -49.4% | -21.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 92.0% | 91.5% | 45.6% | 36.7% | -33.4% | -77.3% | -94.3% | -33.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 63.1% | 56.7% | 37.6% | 32.7% | -106.8% | - | -177.3% | -40.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 66.7% | 44.3% | 38.5% | -106.8% | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.9 | 0.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 239,583 | 187,689 | 89,976 | 107,090 | 40,822 | - | 29,349 | 34,155 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Neurotechnologijos - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-19 | 2026-08-19 | 318.12 |
| 2026-01-16 | 2026-01-20 | 0.45 |
| 2026-01-01 | 2026-01-01 | 0.45 |
| 2025-12-16 | 2025-12-30 | 0.45 |
| 2025-11-18 | 2025-12-04 | 0.45 |
| 2025-10-23 | 2025-11-04 | 0.45 |
| 2025-07-16 | 2025-07-16 | 472.70 |
| 2025-05-16 | 2025-05-25 | 470.08 |
| 2025-04-30 | 2025-04-30 | 168.59 |
| 2025-04-16 | 2025-04-24 | 168.59 |
| 2023-08-17 | 2023-08-24 | 303.96 |
| 2023-07-28 | 2023-08-16 | 1.66 |
| 2023-07-26 | 2023-07-27 | 1.63 |
| 2023-07-24 | 2023-07-25 | 1.67 |
| 2023-07-18 | 2023-07-23 | 1.63 |
| 2023-06-16 | 2023-07-16 | 1.63 |
| 2023-05-16 | 2023-06-13 | 1.63 |
| 2023-05-02 | 2023-05-10 | 1.63 |
| 2023-04-26 | 2023-04-28 | 1.63 |
| 2023-04-18 | 2023-04-25 | 1.60 |
| 2023-03-16 | 2023-04-10 | 1.60 |
| 2023-02-17 | 2023-03-12 | 1.60 |
| 2023-02-06 | 2023-02-06 | 1.60 |
| 2023-01-24 | 2023-02-03 | 1.60 |
| 2023-01-17 | 2023-01-23 | 1.58 |
| 2022-12-16 | 2022-12-28 | 1.58 |
| 2022-11-21 | 2022-12-06 | 1.58 |
| 2022-11-17 | 2022-11-18 | 1.58 |
| 2022-10-28 | 2022-11-03 | 1.58 |
| 2022-10-18 | 2022-10-27 | 1.55 |
| 2022-09-16 | 2022-10-04 | 1.55 |
| 2022-08-23 | 2022-09-05 | 1.55 |
| 2022-07-25 | 2022-08-15 | 1.55 |
| 2022-07-18 | 2022-07-24 | 1.52 |
| 2022-06-16 | 2022-07-10 | 1.52 |
| 2022-05-17 | 2022-06-07 | 1.52 |
| 2022-04-28 | 2022-05-05 | 1.52 |
| 2022-04-19 | 2022-04-27 | 1.50 |
| 2022-03-16 | 2022-04-04 | 1.50 |
| 2022-02-17 | 2022-03-06 | 1.50 |
| 2022-01-18 | 2022-02-10 | 0.50 |
| 2021-12-16 | 2021-12-28 | 0.50 |
| 2021-11-16 | 2021-12-01 | 0.50 |
| 2021-10-18 | 2021-11-07 | 0.50 |
| 2021-09-16 | 2021-10-05 | 0.50 |
Neurotechnologijos - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-18 | 2026-01-27 | 3.05 |
| 2026-01-17 | 2026-01-17 | 1.49 |
| 2026-01-14 | 2026-01-16 | 385.38 |
| 2025-12-24 | 2025-12-28 | 2.18 |
| 2025-12-17 | 2025-12-23 | 0.42 |
| 2025-11-28 | 2025-12-05 | 0.42 |
| 2025-11-20 | 2025-11-24 | 0.42 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Neurotechnologijos, UAB (code 304065589) is a Private Limited Liability Company engaged in research and experimental development on other natural sciences and engineering. In 2025, revenue increased to €68.3K, up 16.4% year on year, while the net loss narrowed to €27.6K from €104.1K in 2024. The company therefore remained loss-making, but profitability improved materially over the year. Over the last three years, revenue moved from -€34.0K in 2023 to €58.7K in 2024 and €68.3K in 2025, while losses declined from €165.8K in 2023. At the end of 2025, total assets stood at €131.8K, with equity of €82.8K and liabilities of €50.6K. Equity represented 62.8% of assets, debt-to-equity was 0.61, and asset turnover was 0.52x. ROE was -33.4% and ROA -21.0%. Revenue per employee was €34.2K, and profit per employee was -€13.8K.